Sage Therapeutics
SAGE
#7471
Rank
NZ$0.49 B
Marketcap
$8.11
Share price
-6.27%
Change (1 day)
-75.33%
Change (1 year)

Sage Therapeutics (SAGE) Fails to deliver data

Key failure to deliver metrics for Sage Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Sage Therapeutics (SAGE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Sage Therapeutics (SAGE) - since 2014

Volume in USD (price x number of shares), data since 2014

Sage Therapeutics (SAGE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$19.32 M83.69%
2023NZ$10.52 M-58.76%
2022NZ$25.51 M144.47%
2021NZ$10.43 M-77.99%
2020NZ$47.42 M9.46%
2019NZ$43.32 M15.08%
2018NZ$37.64 M-39.12%
2017NZ$61.83 M198.96%
2016NZ$20.68 M-69.65%
2015NZ$68.15 M1063.44%
2014NZ$5.85 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0.86 MNZ$6.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.69 MNZ$1.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/ANZ$2.1 M๐Ÿ‡ฎ๐Ÿ‡ช Ireland
N/ANZ$43.08 M๐Ÿ‡บ๐Ÿ‡ธ USA